NEWS

We have two new exciting chemical biology/proteomics postdoc positions available in our group. If you're interested in drug target discovery at the interface between industry & academia please apply! Deadline 17th February 2022.

1: https://bit.ly/3rEcRe0 - Postdoctoral Scientist - Cancer Biology & Systems Pharmacology

2: https://bit.ly/3Ak6uAo - Oxford-BMS Postdoctoral Fellow – Chemical Biology & Proteomics


Congratulations to our friends at Promega & SGC-UNC who have developed a platform to comprehensively study CDK inhibitor target engagement across the whole family in live cells. Very excited we could contribute - check out the full paper now published in Nature Communications:


https://www.nature.com/articles/s41467-020-16559-0


#chemicalprobes #targetengagement #drugdiscovery #CDK



Congratulations to Jenny & Adan on their work on covalent inhibitors of DUBs now published in J. Med. Chem.


https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00144


This has been a great collaboration between the labs of Ed Tate, Benedict Kessler, Olivier Feron, and the Huber group.